References
- 1. Baughman RP. The lung in the immunocompromised patient. Infectious complications Part 1. Respiration. 1999;66(2): 95–109.
- 2. Rañó A, Agustí C, Sibila O, Torres A. Pulmonary infections in non-HIV-immunocompromised patients. Current Opinion in Pulmonary Medicine. 2005;11(3): 213–217.
- 3. Azoulay E, Russell L, Van de Louw A, Metaxa V, Bauer P, Povoa P, et al. Diagnosis of severe respiratory infections in immuno-compromised patients. Intensive Care Medicine. 2020;46(2): 298–314.
- 4. Rubin RH, Young Lowell S, Furth R. Clinical approach to infection in the compromised host. Boston, MA: Springer; 2002. Edition Number 4.
- 5. Di Pasquale MF, Sotgiu G, Gramegna A, Radovanovic D, Terraneo S, Reyes LF, et al. Prevalence and etiology of community-acquired pneumonia in immunocompromised patients. Clinical Infectious Diseases. 2019;68(9): 1482–1493.
- 6. Botnaru V, Rusu D, Chesov D, Brocovschii V, Munteanu O, Toma C, et al. Pneumoniile. Chișinău: Republica Moldova; 2010.
- 7. Botnaru V. Chief of Division of Pneumology and Alergology, Department of Respiratory Medicine, State University of Medicine and Pharmacy “Nicolae Testemitanu”. Chisinau: Moldova; 2014.
- 8. Botnaru V, Chesov D, Corlăteanu A. Pneumonia in condiții de imunitate compromisă. In: Pneumologia; 2009. p.731.
- 9. Vento S, Cainelli F, Temesgen Z. Lung infections after cancer chemotherapy. The Lancet Oncology. 2008;9(10): 982–992.
- 10. Bajaj SK, Tombach B. Respiratory infections in immunocompromised patients: lung findings using chest computed tomography. Radiology of Infectious Diseases. 2017;4(1): 29–37.
- 11. Ryu JH. Chemotherapy-induced pulmonary toxicity in lung cancer patients. Journal of Thoracic Oncology. 2010;5(9): 1313–1314.